Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT03016611

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03016611
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Israel (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03016611. Randomized; no masking; primary purpose treatment. Start 2017-02 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Chewing Ticagrelor Versus Prasugrel in ST-elevation Myocardial Infarction - A Platelet Reactivity Study
Condition
Acute Coronary Syndrome
Condition
STEMI
Intervention (Drug)
Chewing Ticagrelor LD
Intervention (Drug)
Chewing Prasugrel LD
Lead sponsor
Sheba Medical Center (class: other government)

Record details

Record id
cardio:ct-nct03016611
Content hash
aa57c6168694e585f803f1fd7bdc659da38b45417ccfc6f9744dd6490792acf0